Characteristics | |
---|---|
Patient number | 71 |
Age (years), range (median) | 55–89 (77) |
Gender, male/female | 51/20 |
Performance status (0/1/2) | 32/33/6 |
T stage (T1a/T1b/T2a) | 24/33/14 |
Total dose (48 Gy/50 Gy/52 Gy) | 6/51/14 |
Tumor location | |
Center/periphery | 8/63 |
Operability | |
Operable/inoperable | 24/47 |
Operable (T1a/T1b/T2a) | 12/8/4 |
Inoperable (T1a/T1b/T2a) | 12/25/10 |
Histology | |
Adeno/squamous/NSCLC | 50/14/7 |